dronabinol has been researched along with Infarction, Middle Cerebral Artery in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Fazio, V; Dupre Z, T; Hantson, P | 1 |
| Lavie, G; Leker, RR; Ovadia, H; Teichner, A | 1 |
| Abe, K; Egashira, N; Fujiwara, M; Hasebe, N; Hayakawa, K; Ikeda, T; Inui, K; Iwasaki, K; Mishima, K; Takamatsu, F; Yasuda, H | 1 |
| Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Iwasaki, K; Liu, AX; Mishima, K; Nozako, M; Ogata, A | 1 |
| Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Irie, K; Iwasaki, K; Mishima, K; Nozako, M; Orito, K | 1 |
| Aral, E; Arslan, OC; Durmaz, R; Kanbak, G; Kartkaya, K; Ozden, H; Uzuner, K | 1 |
| Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A | 1 |
7 other study(ies) available for dronabinol and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Severe hypoglycemia following massive ischemic stroke in a cannabis-addicted patient treated by a beta-blocking agent.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antihypertensive Agents; Bisoprolol; Brain Edema; Carotid Stenosis; Computed Tomography Angiography; Craniotomy; Dronabinol; Drug Interactions; Female; Glucose; Humans; Hypertension; Hypoglycemia; Infarction, Middle Cerebral Artery; Marijuana Abuse; Marijuana Smoking; Receptors, Adrenergic, beta-1; Receptors, Cannabinoid | 2019 |
Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?
Topics: Animals; Behavior, Animal; Body Weight; Brain Ischemia; Cyclic N-Oxides; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred SHR; Recovery of Function; Spin Labels; Treatment Outcome | 2003 |
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.
Topics: Analysis of Variance; Animals; Body Temperature; Brain Infarction; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fever; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Tetrazolium Salts; Time Factors | 2004 |
Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cannabidiol; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperazines; Piperidines; Pyrazoles; Rimonabant; Serotonin Antagonists; Time Factors | 2007 |
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism.
Topics: Animals; Behavior, Animal; Cannabidiol; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Functional Laterality; Glutamic Acid; Infarction, Middle Cerebral Artery; Male; Mice; Motor Activity; Neuroprotective Agents; Perfusion; Peroxidase; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Tetrazolium Salts; Time Factors | 2007 |
The protective effect of dexanabinol (HU-211) on nitric oxide and cysteine protease-mediated neuronal death in focal cerebral ischemia.
Topics: Animals; Brain Ischemia; Cathepsin B; Cathepsin L; Cathepsins; Cell Death; Cerebral Cortex; Cysteine Endopeptidases; Dronabinol; Humans; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Neurons; Neuroprotective Agents; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley | 2008 |
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
Topics: Animals; Body Weight; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Encephalitis; Free Radicals; Infarction, Middle Cerebral Artery; Male; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred SHR; Tetrazolium Salts | 2001 |